Tristel (TSTL.L) Stock Price
Tristel Price
Revenue has compounded at 14.2% per year over the past 19 years to 46.46 M GBP. Earnings per share have grown at 10.4% per year over the last 19 years. Tristel's net margin stands at 14.3%, up from 11.8% several years earlier. Tristel currently offers a dividend yield of about 3.32%. The payout ratio is around 104% of earnings. The dividend has grown at 14.4% per year over the past 19 years. Analysts set a median price target of 475.32 GBP, implying 11,018.6% above the current price. Of 9 analysts, 7 rate the stock a buy — an overall Buy consensus.
Tristel stock price
Tristel business model & stock analysis
Frequently asked questions about Tristel
The business model of Tristel PLC revolves around providing infection prevention and control products. Tristel manufactures and distributes a range of high-quality disinfectants and sterilants for various industries, including healthcare, veterinary, and contamination control. Their innovative products are used to prevent the spread of diseases and infections in hospitals, clinics, dental surgeries, and other healthcare settings. Tristel PLC aims to offer effective and efficient solutions that ensure safety and hygiene. With a focus on research, development, and quality, Tristel PLC continually strives to meet the evolving needs of the healthcare industry through its dependable products.
Tristel PLC is primarily active in the healthcare and medical industries.
Tristel PLC faces tough competition in the market from several key players. Some of the main competitors of Tristel PLC include Company A, Company B, and Company C. These companies actively participate in the same industry as Tristel PLC, offering similar products and solutions. Tristel PLC strives to stay ahead of its competitors by constantly innovating and delivering high-quality products to its customers. Adhering to stringent quality standards, Tristel PLC continues to maintain its competitive edge in the market.
Tristel PLC is a renowned company with a rich history and background. Established in 1993, Tristel specializes in infection prevention and control solutions for healthcare environments. The company has continuously expanded its product range and gained a strong foothold in the market. Tristel PLC is known for its innovative and high-quality products, which are effective against a broad spectrum of microorganisms. With a commitment to research and development, Tristel has achieved significant growth and success in the global healthcare industry. The company's dedication to providing superior infection control solutions has earned Tristel PLC a reputable name in the market, making it a preferred choice for healthcare professionals worldwide.
Tristel PLC has achieved several significant milestones throughout its history. One notable achievement is its successful expansion into global markets, allowing the company to establish a strong international presence. Furthermore, Tristel PLC has consistently shown impressive revenue growth, indicating its ability to deliver strong financial performance. The company has also gained recognition for its innovative products and solutions, receiving numerous accolades and industry awards. With a commitment to research and development, Tristel PLC has continuously introduced cutting-edge technologies to the market, further solidifying its reputation as a leading player in the industry.
Tristel PLC, a leading healthcare company, primarily operates in several countries and regions worldwide. With a global presence, Tristel has established its footprint in key markets across Europe, North America, Asia Pacific, and the Middle East. The company's extensive reach spans countries like the United Kingdom, Germany, France, Italy, Spain, the United States, Canada, Australia, China, Japan, India, and the United Arab Emirates. Tristel PLC's multinational presence enables them to deliver innovative infection prevention and control solutions to a wide range of healthcare professionals and institutions across diverse geographical regions.
Tristel PLC represents a set of core values and a corporate philosophy centered around innovation, excellence, and customer focus. As a leading manufacturer of infection prevention and contamination control products, Tristel is committed to delivering cutting-edge solutions that uphold the highest standards of efficacy and safety. With a strong emphasis on product development and technological advancements, Tristel aims to provide healthcare professionals with reliable, evidence-based solutions to combat infection risks. Through its unwavering dedication to quality, integrity, and customer satisfaction, Tristel PLC continually strives to make a positive impact in the healthcare industry and improve patient outcomes.
Analysts currently set an average price target of 482.46 GBP for the Tristel stock (median: 475.32 GBP), implying +12.9 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Tristel stock: 7 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Tristel to generate revenue of 51.09 M GBP and earnings per share of 0.17 GBP.
Converted at the current exchange rate, the Tristel share trades at 5.04 EUR (4.28 GBP).
The Tristel share (TSTL.L) is listed on 4 stock exchanges, including: London (TSTL.L), Frankfurt (R1V.F).
Tristel PLC is a British company specializing in the manufacture and sale of hygiene and disinfection products. The company offers a wide range of products used in various applications in the medical, veterinary, food industry, and other industries. The business model of Tristel PLC is based on three main divisions: Medical instrument reprocessing, hospital disinfection, and animal health. Each division is focused on a specific segment of the market and offers specialized products. The medical instrument reprocessing division provides cleaning and disinfection solutions for medical devices, especially endoscopes. Tristel PLC offers a wide range of products, including Tristel Duo, Tristel Sporicidal Wipes, and Tristel Fuse for ENT, specifically designed for effective cleaning and disinfection of endoscopes. The products aim to prevent infections caused by dirty or improperly reprocessed instruments. The second division of Tristel PLC focuses on hospital disinfection. The company offers a wide range of products specifically designed for disinfecting hospitals and clinical areas. The products range from disinfection wipes to generator systems that produce a fine aerosol using ultrasound, allowing for disinfection of larger areas. The products help reduce the spread of infections in hospitals and clinical facilities. The animal health division of Tristel PLC offers products that help veterinarians and pet owners protect their animals from infections and diseases. The products range from simple disinfectants to more specialized solutions like Tristel Trio Animalcare, used for disinfecting medical devices used in animals. Tristel PLC not only offers products but also provides consultancy and training to its customers. The company offers training on products and procedures to ensure that customers effectively use the products and achieve optimal results. Tristel PLC sells its products in over 40 countries worldwide. The company has expanded its presence in various markets through acquisitions and strategic partnerships, such as the acquisition of Anistel, a company specializing in animal health. The business model of Tristel PLC aims to establish hygiene and disinfection as a necessary component in various areas of society while ensuring that customers receive the most effective products and procedures. The company follows a corporate philosophy focusing on innovation, quality, and customer care to ensure that it always provides its customers with the best products and services. Answer: Tristel PLC is a British company specializing in hygiene and disinfection products. It has three main divisions: medical instrument reprocessing, hospital disinfection, and animal health. The company offers a range of products for each division and also provides training and consultancy. Tristel PLC sells its products globally and aims to establish hygiene and disinfection as essential components of various industries.
The expected revenue of Tristel is 51.09 M GBP. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Tristel is 8.43 M GBP. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Tristel is currently 24.79. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Tristel stock.
The price-to-sales ratio (P/S) of Tristel is currently 4.09. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Tristel stock.
The Eulerpool Quality Score for Tristel is 8/10.
The ISIN of Tristel is GB00B07RVT99. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Tristel is A0JDM7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Tristel is TSTL.L. The ticker symbol is used to trade Tristel shares on the stock exchange.
Tristel stock
Tristel Peer Group
Tristel Ticker
Tristel FIGI
All fundamentals and in-depth analysis of Tristel
Our stock analysis for Tristel stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tristel. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.